CEO and President Ankit Mahadevia sold $44K of Spero Therapeutics, Inc.

Sold$43,552

$14.29Price

3,047Shares

−4%Stake

What SPRO did after the filing

Prices for SPRO after this filing aren't in yet.

Traded Tue, Jul 7. Filed Thu, Jul 9, 2:48 PM ET, during the session. Not investment advice.